Linda Kahr Andersen1, Kirsten Lykke Knak2, Nanna Witting2, John Vissing2. 1. From the Copenhagen Neuromuscular Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Denmark. linda.kahr.andersen@regionh.dk. 2. From the Copenhagen Neuromuscular Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Denmark.
Abstract
OBJECTIVE: This methodologic study investigates if the 2-minute walk test (2MWT) can be a valid alternative to the 6-minute walk test (6MWT) to describe walking capability in patients with neuromuscular diseases. METHODS:Patients (n = 115) with different neuromuscular diseases were invited to participate on 2 test days, each consisting of 1 2MWT and 1 6MWT separated by a minimum 30-minute period of rest. The order of the walk tests was randomly assigned via sealed envelopes. A group of 38 healthy controls completed 16MWT. RESULTS: The mean walking distance for the 2MWT was 142.8 meters and for the 6MWT 405.3 meters. The distance walked in the 2MWT was highly correlated to the distance walked in the 6MWT (r = 0.99, p < 0.001). There was a significant decrease in walking speed from the first to last minute in the 6MWT, both among patients and healthy controls, which was not evident in the 2MWT. Results were consistent across diagnoses and levels of disease severity. CONCLUSION: The 2MWT is a potential alternative to the 6MWT to describe walking capability among patients with neuromuscular diseases during clinical trials.
RCT Entities:
OBJECTIVE: This methodologic study investigates if the 2-minute walk test (2MWT) can be a valid alternative to the 6-minute walk test (6MWT) to describe walking capability in patients with neuromuscular diseases. METHODS:Patients (n = 115) with different neuromuscular diseases were invited to participate on 2 test days, each consisting of 1 2MWT and 1 6MWT separated by a minimum 30-minute period of rest. The order of the walk tests was randomly assigned via sealed envelopes. A group of 38 healthy controls completed 1 6MWT. RESULTS: The mean walking distance for the 2MWT was 142.8 meters and for the 6MWT 405.3 meters. The distance walked in the 2MWT was highly correlated to the distance walked in the 6MWT (r = 0.99, p < 0.001). There was a significant decrease in walking speed from the first to last minute in the 6MWT, both among patients and healthy controls, which was not evident in the 2MWT. Results were consistent across diagnoses and levels of disease severity. CONCLUSION: The 2MWT is a potential alternative to the 6MWT to describe walking capability among patients with neuromuscular diseases during clinical trials.
Authors: V J Block; A Lizée; E Crabtree-Hartman; C J Bevan; J S Graves; R Bove; A J Green; B Nourbakhsh; M Tremblay; P-A Gourraud; M Y Ng; M J Pletcher; J E Olgin; G M Marcus; D D Allen; B A C Cree; J M Gelfand Journal: J Neurol Date: 2016-11-28 Impact factor: 4.849
Authors: Andrew S Monaghan; Patrick G Monaghan; Sutton B Richmond; Jamie A Roper; Brett W Fling Journal: Exp Brain Res Date: 2021-07-01 Impact factor: 1.972
Authors: J W Witherspoon; R Vasavada; R H Logaraj; M Waite; J Collins; C Shieh; K Meilleur; C Bönnemann; M Jain Journal: Eur J Paediatr Neurol Date: 2018-10-23 Impact factor: 3.140
Authors: Jan Szczegielniak; Krzysztof J Latawiec; Jacek Łuniewski; Rafał Stanisławski; Katarzyna Bogacz; Marcin Krajczy; Marek Rydel Journal: PLoS One Date: 2018-02-09 Impact factor: 3.240
Authors: Marc Bolliger; Andrew R Blight; Edelle C Field-Fote; Kristin Musselman; Serge Rossignol; Dorothy Barthélemy; Laurent Bouyer; Milos R Popovic; Jan M Schwab; Michael L Boninger; Keith E Tansey; Giorgio Scivoletto; Naomi Kleitman; Linda A T Jones; Dany H Gagnon; Sylvie Nadeau; Dirk Haupt; Lea Awai; Chris S Easthope; Björn Zörner; Ruediger Rupp; Dan Lammertse; Armin Curt; John Steeves Journal: Spinal Cord Date: 2018-04-27 Impact factor: 2.772
Authors: Jessica W Witherspoon; Ruhi P Vasavada; Melissa R Waite; Monique Shelton; Irene C Chrismer; Paul G Wakim; Minal S Jain; Carsten G Bönnemann; Katherine G Meilleur Journal: Orphanet J Rare Dis Date: 2018-07-03 Impact factor: 4.123